107 related articles for article (PubMed ID: 8593495)
1. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice.
Miura T; Usami M; Tsuura Y; Ishida H; Seino Y
Biol Pharm Bull; 1995 Nov; 18(11):1623-5. PubMed ID: 8593495
[TBL] [Abstract][Full Text] [Related]
2. Docosahexanoic acid (DHA) improved glucose and lipid metabolism in KK-Ay mice with genetic non-insulin-dependent diabetes mellitus (NIDDM).
Shimura T; Miura T; Usami M; Ishihara E; Tanigawa K; Ishida H; Seino Y
Biol Pharm Bull; 1997 May; 20(5):507-10. PubMed ID: 9178930
[TBL] [Abstract][Full Text] [Related]
3. Determination of hemoglobin A1C in normal and diabetic mice: neonatal streptozotocin-induced diabetic mice and KK-Ay mice.
Kitazawa N; Miura T; Kako M; Usami M; Tanigawa K; Ishida H; Seino Y
Biol Pharm Bull; 1996 Aug; 19(8):1078-9. PubMed ID: 8874820
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice.
Hayashi K; Ito M
Biol Pharm Bull; 2002 Feb; 25(2):188-92. PubMed ID: 11853163
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats.
Lee HW; Park YS; Choi JW; Yi SY; Shin WS
Biol Pharm Bull; 2003 Aug; 26(8):1100-3. PubMed ID: 12913258
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic activity of to-kai-san (Chinese medicines) in normal and KK-Ay mice.
Miura T; Noda M; Fukunaga T; Furuta K
J Nutr Sci Vitaminol (Tokyo); 1997 Feb; 43(1):11-7. PubMed ID: 9151237
[TBL] [Abstract][Full Text] [Related]
7. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice.
Kondo Y; Nakatani A; Hayashi K; Ito M
Biol Pharm Bull; 2000 Dec; 23(12):1458-64. PubMed ID: 11145178
[TBL] [Abstract][Full Text] [Related]
10. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholesterolemia.
Tai TS; Sheu WH; Lee WJ; Yao HT; Chiang MT
Diabetes Care; 2000 Nov; 23(11):1703-4. PubMed ID: 11092297
[No Abstract] [Full Text] [Related]
11. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats.
Yao HT; Huang SY; Chiang MT
Food Chem Toxicol; 2008 May; 46(5):1525-34. PubMed ID: 18255211
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic effect of S-adenosylmethionine and α-glycerophosphocholine in KK-A
Izu H; Okuda M; Shibata S; Fujii T; Matsubara K
Biosci Biotechnol Biochem; 2019 Apr; 83(4):747-750. PubMed ID: 30582404
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemic effect of the rhizomes of Polygala senega in normal and diabetic mice and its main component, the triterpenoid glycoside senegin-II.
Kako M; Miura T; Nishiyama Y; Ichimaru M; Moriyasu M; Kato A
Planta Med; 1996 Oct; 62(5):440-3. PubMed ID: 8923811
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic effect of the rhizomes of Smilax glabra in normal and diabetic mice.
Fukunaga T; Miura T; Furuta K; Kato A
Biol Pharm Bull; 1997 Jan; 20(1):44-6. PubMed ID: 9013805
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemic effect of the rhizomes of ophiopogonis tuber in normal and diabetic mice.
Kako M; Miura T; Usami M; Kato A; Kadowaki S
Biol Pharm Bull; 1995 May; 18(5):785-7. PubMed ID: 7493002
[TBL] [Abstract][Full Text] [Related]
17. Effect of senegin-II on blood glucose in normal and NIDDM mice.
Kako M; Miura T; Usami M; Nishiyama Y; Ichimaru M; Moriyasu M; Kato A
Biol Pharm Bull; 1995 Aug; 18(8):1159-61. PubMed ID: 8535417
[TBL] [Abstract][Full Text] [Related]
18. The suppressive effect of mangiferin with exercise on blood lipids in type 2 diabetes.
Miura T; Iwamoto N; Kato M; Ichiki H; Kubo M; Komatsu Y; Ishida T; Okada M; Tanigawa K
Biol Pharm Bull; 2001 Sep; 24(9):1091-2. PubMed ID: 11558577
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice.
Ohnishi M; Matuo T; Tsuno T; Hosoda A; Nomura E; Taniguchi H; Sasaki H; Morishita H
Biofactors; 2004; 21(1-4):315-9. PubMed ID: 15630218
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic effect of Nitobegiku, the herb Tithonia diversifolia, in KK-Ay diabetic mice.
Miura T; Nosaka K; Ishii H; Ishida T
Biol Pharm Bull; 2005 Nov; 28(11):2152-4. PubMed ID: 16272709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
